tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ZLDAF Stock Latest News

Zelira Therapeutics’ ZLT-L-007 Shows Promising Results in Diabetic Neuropathy Study
Company AnnouncementsZelira Therapeutics’ ZLT-L-007 Shows Promising Results in Diabetic Neuropathy Study
2d ago
Zelira Therapeutics Strengthens Financial Position and Advances Product Development
PremiumCompany Announcements
Zelira Therapeutics Strengthens Financial Position and Advances Product Development
25d ago
Zelira Therapeutics Converts $3.25M Notes to Equity, Advances Autism Treatment Trials
PremiumCompany Announcements
Zelira Therapeutics Converts $3.25M Notes to Equity, Advances Autism Treatment Trials
26d ago
Zelira Therapeutics Unveils Strategic Investor Deck
PremiumCompany Announcements
Zelira Therapeutics Unveils Strategic Investor Deck
2M ago
Zelira Therapeutics Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Zelira Therapeutics Expands Market Presence with New Securities Quotation
2M ago
Zelira Therapeutics Launches Share Offer to Raise Capital
PremiumCompany AnnouncementsZelira Therapeutics Launches Share Offer to Raise Capital
2M ago
Zelira Therapeutics Announces Proposed Issue of 550,000 Securities
Premium
Company Announcements
Zelira Therapeutics Announces Proposed Issue of 550,000 Securities
2M ago
Zelira Therapeutics Secures $1 Million ATM Funding for Growth
Premium
Company Announcements
Zelira Therapeutics Secures $1 Million ATM Funding for Growth
2M ago
Zelira Therapeutics Advances Autism Drug Program with FDA Support and Patent Secures
PremiumCompany Announcements
Zelira Therapeutics Advances Autism Drug Program with FDA Support and Patent Secures
3M ago
Zelira Therapeutics Secures $1.15M R&D Tax Incentive Refund to Bolster Operations
PremiumCompany Announcements
Zelira Therapeutics Secures $1.15M R&D Tax Incentive Refund to Bolster Operations
3M ago
Zelira Therapeutics Advances HOPE® Program with Secured FDA Trial Funding
PremiumCompany Announcements
Zelira Therapeutics Advances HOPE® Program with Secured FDA Trial Funding
4M ago
Zelira Therapeutics Secures Fourth Funding Tranche to Advance FDA Trials
PremiumCompany Announcements
Zelira Therapeutics Secures Fourth Funding Tranche to Advance FDA Trials
4M ago
Zelira Therapeutics Announces Change in Director’s Interest
PremiumCompany AnnouncementsZelira Therapeutics Announces Change in Director’s Interest
4M ago
Zelira Therapeutics Issues Convertible Notes
Premium
Company Announcements
Zelira Therapeutics Issues Convertible Notes
5M ago
Zelira Therapeutics Issues 3.5 Million Convertible Notes
Premium
Company Announcements
Zelira Therapeutics Issues 3.5 Million Convertible Notes
5M ago
Zelira Therapeutics Unveils Growth Plans at Investment Conference
PremiumCompany Announcements
Zelira Therapeutics Unveils Growth Plans at Investment Conference
6M ago
Zelira Therapeutics Secures Shareholder Support at AGM
PremiumCompany Announcements
Zelira Therapeutics Secures Shareholder Support at AGM
6M ago
Zelira Therapeutics Prepares for 2024 Shareholders Meeting
PremiumCompany Announcements
Zelira Therapeutics Prepares for 2024 Shareholders Meeting
6M ago
Zelira Therapeutics’ Financials: Borrowings Boost Cash Flow
PremiumCompany Announcements
Zelira Therapeutics’ Financials: Borrowings Boost Cash Flow
7M ago
Zelira Therapeutics Advances in FDA Trials and Product Development
PremiumCompany AnnouncementsZelira Therapeutics Advances in FDA Trials and Product Development
7M ago
Zelira Therapeutics Schedules Hybrid 2024 AGM
Premium
Company Announcements
Zelira Therapeutics Schedules Hybrid 2024 AGM
7M ago
Zelira Therapeutics Announces Upcoming AGM
Premium
Company Announcements
Zelira Therapeutics Announces Upcoming AGM
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >